Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations
Abstract Randomized controlled trials (RCTs) are regarded as the most reputable source of evidence. In some studies, factors beyond the intervention itself may contribute to the measured effect, an occurrence known as heterogeneity of treatment effect (HTE). If the RCT population differs from the re...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f2941ae407db4ad197e6d29fe2663bf3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f2941ae407db4ad197e6d29fe2663bf3 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f2941ae407db4ad197e6d29fe2663bf32021-12-02T15:36:31ZTranslating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations10.1038/s41746-020-0277-82398-6352https://doaj.org/article/f2941ae407db4ad197e6d29fe2663bf32020-05-01T00:00:00Zhttps://doi.org/10.1038/s41746-020-0277-8https://doaj.org/toc/2398-6352Abstract Randomized controlled trials (RCTs) are regarded as the most reputable source of evidence. In some studies, factors beyond the intervention itself may contribute to the measured effect, an occurrence known as heterogeneity of treatment effect (HTE). If the RCT population differs from the real-world population on factors that induce HTE, the trials effect will not replicate. The RCTs eligibility criteria should identify the sub-population in which its evidence will replicate. However, the extent to which the eligibility criteria identify the appropriate population is unknown, which raises concerns for generalizability. We compared reported data from RCTs with real-world data from the electronic health records of a large, academic medical center that was curated according to RCT eligibility criteria. Our results show fundamental differences between the RCT population and our observational cohorts, which suggests that eligibility criteria may be insufficient for identifying the applicable real-world population in which RCT evidence will replicate.Amelia J. AverittChunhua WengPatrick RyanAdler PerotteNature PortfolioarticleComputer applications to medicine. Medical informaticsR858-859.7ENnpj Digital Medicine, Vol 3, Iss 1, Pp 1-10 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Computer applications to medicine. Medical informatics R858-859.7 |
spellingShingle |
Computer applications to medicine. Medical informatics R858-859.7 Amelia J. Averitt Chunhua Weng Patrick Ryan Adler Perotte Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations |
description |
Abstract Randomized controlled trials (RCTs) are regarded as the most reputable source of evidence. In some studies, factors beyond the intervention itself may contribute to the measured effect, an occurrence known as heterogeneity of treatment effect (HTE). If the RCT population differs from the real-world population on factors that induce HTE, the trials effect will not replicate. The RCTs eligibility criteria should identify the sub-population in which its evidence will replicate. However, the extent to which the eligibility criteria identify the appropriate population is unknown, which raises concerns for generalizability. We compared reported data from RCTs with real-world data from the electronic health records of a large, academic medical center that was curated according to RCT eligibility criteria. Our results show fundamental differences between the RCT population and our observational cohorts, which suggests that eligibility criteria may be insufficient for identifying the applicable real-world population in which RCT evidence will replicate. |
format |
article |
author |
Amelia J. Averitt Chunhua Weng Patrick Ryan Adler Perotte |
author_facet |
Amelia J. Averitt Chunhua Weng Patrick Ryan Adler Perotte |
author_sort |
Amelia J. Averitt |
title |
Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations |
title_short |
Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations |
title_full |
Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations |
title_fullStr |
Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations |
title_full_unstemmed |
Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations |
title_sort |
translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/f2941ae407db4ad197e6d29fe2663bf3 |
work_keys_str_mv |
AT ameliajaveritt translatingevidenceintopracticeeligibilitycriteriafailtoeliminateclinicallysignificantdifferencesbetweenrealworldandstudypopulations AT chunhuaweng translatingevidenceintopracticeeligibilitycriteriafailtoeliminateclinicallysignificantdifferencesbetweenrealworldandstudypopulations AT patrickryan translatingevidenceintopracticeeligibilitycriteriafailtoeliminateclinicallysignificantdifferencesbetweenrealworldandstudypopulations AT adlerperotte translatingevidenceintopracticeeligibilitycriteriafailtoeliminateclinicallysignificantdifferencesbetweenrealworldandstudypopulations |
_version_ |
1718386327437705216 |